INFI Infinity Pharmaceuticals, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

INFI [NASD]

Infinity Pharmaceuticals, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-0.76	Insider Own	0.30%	Shs Outstand	57.44M	Perf Week	-4.07%
Market Cap	68.31M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	0.00%	Shs Float	55.29M	Perf Month	11.32%
Income	-43.20M	PEG	-	EPS next Q	-0.16	Inst Own	55.10%	Short Float	0.30%	Perf Quarter	42.17%
Sales	1.40M	P/S	48.79	EPS this Y	-306.60%	Inst Trans	10.38%	Short Ratio	0.30	Perf Half Y	7.27%
Book/sh	-0.20	P/B	-	EPS next Y	-7.80%	ROA	-80.70%	Target Price	-	Perf Year	10.28%
Cash/sh	0.74	P/C	1.60	EPS next 5Y	-	ROE	-	52W Range	0.60 - 1.68	Perf YTD	22.92%
Dividend	-	P/FCF	-	EPS past 5Y	-18.20%	ROI	-592.30%	52W High	-29.76%	Beta	1.82
Dividend %	-	Quick Ratio	5.00	Sales past 5Y	-55.00%	Gross Margin	39.70%	52W Low	96.67%	ATR	0.06
Employees	25	Current Ratio	5.00	Sales Q/Q	33.30%	Oper. Margin	-	RSI (14)	51.68	Volatility	4.31% 4.86%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	10.70%	Profit Margin	-	Rel Volume	0.27	Prev Close	1.18
Shortable	Yes	LT Debt/Eq	-	Earnings	Jul 30 AMC	Payout	-	Avg Volume	548.58K	Price	1.18
Recom	2.40	SMA20	0.92%	SMA50	3.46%	SMA200	11.82%	Volume	149,372	Change	0.00%

Jun-27-19

Initiated

Oppenheimer

Outperform

Jan-04-19

Initiated

B. Riley FBR

Buy

Nov-12-18

Downgrade

Wells Fargo

Outperform → Market Perform

Nov-12-18

Downgrade

JP Morgan

Neutral → Underweight

Oct-12-17

Upgrade

Wells Fargo

Market Perform → Outperform

Aug-10-16

Reiterated

Wedbush

Neutral

$1.25 → $1

Jun-15-16

Downgrade

Wells Fargo

Outperform → Market Perform

Jun-15-16

Downgrade

RBC Capital Mkts

Outperform → Sector Perform

$12 → $2

Jun-15-16

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Jun-15-16

Downgrade

Jefferies

Buy → Hold

Jun-14-16

Downgrade

JP Morgan

Overweight → Neutral

Jun-14-16

Downgrade

JMP Securities

Mkt Outperform → Mkt Perform

Jun-14-16

Downgrade

FBR Capital

Outperform → Mkt Perform

$15 → $2

Mar-02-16

Initiated

FBR Capital

Outperform

$15

Feb-25-16

Reiterated

Wedbush

Neutral

$9 → $8

Sep-21-15

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Aug-07-15

Reiterated

RBC Capital Mkts

Outperform

$18 → $15

May-07-15

Initiated

Deutsche Bank

Buy

$20

Oct-20-14

Resumed

Stifel

Hold

Mar-06-13

Reiterated

Stifel

Buy

$39 → $50

Oct-11-20 10:58AM	Would Shareholders Who Purchased Infinity Pharmaceuticals' (NASDAQ:INFI) Stock Five Years Be Happy With The Share price Today? Simply Wall St.
Sep-30-20 09:15AM	Infinity's Eganelisib Gets Fast Track Tag for Breast Cancer Zacks
Sep-29-20 07:35AM	Infinity Receives Fast Track Designation for Eganelisib in Combination with a Checkpoint Inhibitor and Chemotherapy for First-Line Treatment of Advanced TNBC Business Wire
Sep-04-20 08:05AM	Infinity to Present at Upcoming Investor Conferences in September Business Wire
Aug-11-20 08:49AM	How Much Is Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Paying Its CEO? Simply Wall St. +9.35%
08:39AM	Infinity Pharmaceuticals (NASDAQ:INFI) Will Have To Spend Its Cash Wisely Simply Wall St.
Aug-10-20 03:30PM	3 Strong Buy Penny Stocks With Triple-Digit Upside Potential TipRanks +9.17%
Jul-30-20 06:30PM	Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM	Infinity Pharmaceuticals Provides Company Update and Second Quarter 2020 Financial Results Business Wire
Jul-23-20 07:35AM	Infinity Announces the Date of Its Second Quarter Financial Results Conference Call and Webcast Business Wire
Jul-08-20 08:22AM	Edited Transcript of INFI.OQ earnings conference call or presentation 11-May-20 8:30pm GMT Thomson Reuters StreetEvents +19.77%
Jun-10-20 03:46PM	Hedge Funds Not Interested In Infinity Pharmaceuticals Inc. (INFI) Anymore Insider Monkey
11:30AM	Infinity (INFI) Up 4% Since Last Earnings Report: Can It Continue? Zacks
08:45AM	Infinity (INFI) Looks Good: Stock Adds 5.3% in Session Zacks
Jun-04-20 08:35AM	Infinity Pharmaceuticals to Host a Virtual-Only 2020 Annual Meeting of Stockholders Business Wire
May-12-20 12:48PM	Infinity (INFI) Q1 Earnings Lag Estimates, IPI-549 in Focus Zacks -6.63%
May-11-20 08:55AM	Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue Estimates Zacks -9.01%
07:35AM	Infinity Pharmaceuticals Provides Company Update and First Quarter 2020 Financial Results Business Wire
May-04-20 07:35AM	Infinity Announces the Date of Its First Quarter Financial Results Conference Call and Webcast Business Wire
Apr-28-20 12:33PM	Will Infinity Pharmaceuticals (INFI) Report Negative Q1 Earnings? What You Should Know Zacks
Apr-20-20 07:59AM	If You Had Bought Infinity Pharmaceuticals (NASDAQ:INFI) Stock Five Years Ago, You'd Be Sitting On A 93% Loss, Today Simply Wall St.
Apr-10-20 12:00PM	Infinity (INFI) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Apr-07-20 07:35AM	Infinity Pharmaceuticals Provides Update in Response to COVID-19 Pandemic Business Wire
Apr-02-20 11:30AM	Infinity (INFI) Down 28.2% Since Last Earnings Report: Can It Rebound? Zacks -6.49%
Mar-26-20 06:07PM	Infinity's IPI-549 Gets Fast Track Tag for Urothelial Cancer Zacks
09:35AM	Company News for Mar 26, 2020 Zacks
Mar-25-20 07:35AM	Infinity Receives Fast Track Designation for IPI-549 in Combination with the Checkpoint Inhibitor Opdivo for the Treatment of Advanced Urothelial Cancer Business Wire +12.05%
Mar-17-20 01:49PM	Edited Transcript of INFI earnings conference call or presentation 3-Mar-20 9:30pm GMT Thomson Reuters StreetEvents
07:35AM	Infinity Pharmaceuticals Augments Board of Directors with Appointment of Richard Gaynor, M.D. Business Wire
Mar-04-20 03:31PM	Infinity (INFI) Q4 Loss Wider Than Expected, IPI-549 in Focus Zacks
Mar-03-20 05:35PM	Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Tops Revenue Estimates Zacks -6.78%
04:05PM	Infinity Pharmaceuticals Reports Full Year 2019 Financial Results and Provides Company Update Business Wire
Feb-25-20 07:35AM	Infinity Announces the Date of Its Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast Business Wire
Jan-23-20 08:34AM	What Kind Of Share Price Volatility Should You Expect For Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)? Simply Wall St.
Jan-13-20 07:35AM	Infinity Pharmaceuticals Provides 2020 Goals and Financial Guidance Business Wire -5.60%
Jan-09-20 09:00AM	Verastem In-Licenses KRAS-Focused Drug From Chugai, Stock Up Zacks +11.21%
07:35AM	Infinity Pharmaceuticals Raises $20 Million Through an Innovative Non-Dilutive Asset-Backed Financing from BVF Business Wire
07:05AM	Infinity Pharmaceuticals to Present Corporate Overview at 38th Annual J.P. Morgan Global Healthcare Conference Business Wire
Dec-20-19 06:23PM	Infinity Pharmaceuticals Inc. (INFI): Are Hedge Funds Right About This Stock? Insider Monkey
Nov-09-19 10:24PM	Edited Transcript of INFI earnings conference call or presentation 30-Oct-19 8:30pm GMT Thomson Reuters StreetEvents
Oct-31-19 12:45PM	Infinity (INFI) Q3 Loss Wider Than Expected, IPI-549 in Focus Zacks
Oct-30-19 06:25PM	Infinity Pharmaceuticals (INFI) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:03PM	Infinity Pharmaceuticals Provides Company Update and Third Quarter 2019 Financial Results Business Wire
Oct-23-19 08:33AM	Infinity Announces the Date of Its Third Quarter 2019 Financial Results Conference Call and Webcast Business Wire
Oct-08-19 10:02AM	Verastem's (VSTM) Copiktra Gets Orphan Drug Designation Zacks
09:18AM	Infinity's (INFI) IPI-549 in Focus in a Crowded Cancer Space Zacks
Sep-05-19 10:24AM	Infinity Initiates 2 Studies for Lead Candidate IPI-549 Zacks
Sep-04-19 08:32AM	Infinity Pharmaceuticals Announces the Initiation of Two Clinical Trials Evaluating IPI-549 in Novel Triple Combination Therapies for the Treatment of Solid Tumors PR Newswire
Sep-03-19 08:32AM	Infinity to Present at Two Upcoming Conferences in September PR Newswire
Aug-29-19 09:31AM	Infinity (INFI) Down 22.5% Since Last Earnings Report: Can It Rebound? Zacks
Aug-22-19 04:03PM	Infinity Pharmaceuticals Announces Transition of Samuel Agresta, M.D., from Chief Medical Officer to Board of Directors PR Newswire
Aug-03-19 07:50AM	Edited Transcript of INFI earnings conference call or presentation 30-Jul-19 12:00pm GMT Thomson Reuters StreetEvents
Jul-31-19 10:16AM	Infinity (INFI) Q2 Loss Wider Than Expected, Sales Miss Zacks -6.37%
Jul-30-19 08:55AM	Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Lags Revenue Estimates Zacks
07:32AM	Infinity Pharmaceuticals Provides Company Update and Second Quarter 2019 Financial Results PR Newswire
Jul-23-19 08:32AM	Infinity Announces The Date Of Its Second Quarter 2019 Financial Results Conference Call And Webcast PR Newswire -5.99%
Jun-24-19 08:33AM	Verastem Up on Positive Data From Early-Stage Copiktra Study Zacks
Jun-06-19 09:31AM	Infinity (INFI) Up 6% Since Last Earnings Report: Can It Continue? Zacks
May-29-19 08:32AM	Infinity Pharmaceuticals To Present At The 2019 BIO International Convention PR Newswire
May-16-19 08:32AM	Infinity Pharmaceuticals To Present At B. Riley FBR Institutional Investor Conference PR Newswire
May-15-19 12:54AM	Edited Transcript of INFI earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-08-19 09:33AM	Infinity (INFI) Earnings and Sales Miss Estimates in Q1 Zacks -11.76%
May-07-19 07:25PM	Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Lags Revenue Estimates Zacks
06:14PM	Infinity: 1Q Earnings Snapshot Associated Press
04:05PM	Infinity Pharmaceuticals Provides Company Update and First Quarter 2019 Financial Results PR Newswire
Apr-30-19 08:32AM	Infinity Announces the Date of Its First Quarter 2019 Financial Results Conference Call and Webcast PR Newswire
Apr-13-19 09:30AM	Infinity (INFI) Down 10% Since Last Earnings Report: Can It Rebound? Zacks
Apr-10-19 11:10AM	Beat Q1 Earnings Woes With These Sector ETFs & Stocks Zacks
Apr-02-19 08:32AM	Infinity Pharmaceuticals To Present At The 18th Annual Needham Healthcare Conference PR Newswire -5.35%
Mar-28-19 08:21AM	Will Infinity Pharmaceuticals Continue to Surge Higher? Zacks
Mar-25-19 09:00AM	Infinity (INFI) Upgraded to Buy: Here's What You Should Know Zacks
Mar-22-19 10:10PM	Edited Transcript of INFI earnings conference call or presentation 14-Mar-19 12:00pm GMT Thomson Reuters StreetEvents
Mar-18-19 11:26AM	Karyopharm Stock Up Even as FDA Delays Selinexor NDA Verdict Zacks
09:22AM	Spectrum Pharma (SPPI) Withdraws Rolontis BLA, Shares Down Zacks
Mar-15-19 11:37AM	Infinity Inks Deal With Roche for Phase II Study of IPI-549 Zacks -5.76%
Mar-14-19 09:50AM	Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Tops Revenue Estimates Zacks +24.03%
08:52AM	Infinity: 4Q Earnings Snapshot Associated Press
07:32AM	Infinity Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Company Update PR Newswire
07:02AM	Infinity To Initiate MARIO-3, A Phase 2 Multi-Arm Study Evaluating IPI-549 In Front-Line Triple Negative Breast Cancer And Renal Cell Cancer PR Newswire
05:00AM	Infinity Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-07-19 04:05PM	Infinity Announces the Date of Its Full Year 2018 Financial Results Conference Call and Webcast PR Newswire -9.36%
Mar-06-19 07:32AM	Infinity Pharmaceuticals Announces Royalty Monetization of COPIKTRA for $30 Million Gross Proceeds PR Newswire
Feb-06-19 07:55AM	Analysis: Positioning to Benefit within Conagra Brands, National Retail Properties, PRA Health Sciences, Westinghouse Air Brake Technologies, YRC Worldwide, and Infinity Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-04-19 08:32AM	Infinity Pharmaceuticals To Present At BIO CEO & Investor Conference PR Newswire
Jan-07-19 07:32AM	Infinity Pharmaceuticals Provides 2019 Goals and Financial Guidance PR Newswire +8.87%
Jan-03-19 04:05PM	Infinity To Present At 37th Annual J.P. Morgan Healthcare Conference PR Newswire -5.60%
Dec-05-18 09:30AM	Infinity (INFI) Down 48.3% Since Last Earnings Report: Can It Rebound? Zacks
Nov-13-18 07:26AM	Edited Transcript of INFI earnings conference call or presentation 5-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
06:55AM	Todays Research Reports on Stocks to Watch: Infinity Pharmaceuticals and athenahealth ACCESSWIRE
Nov-10-18 06:02AM	Infinity Reports Clinical and Translational Data from Expansion Cohorts of MARIO1 Phase 1b Study of IPI-549 in Combination with Opdivo® (nivolumab) at SITC's 33rd Annual Meeting PR Newswire
Nov-09-18 08:35AM	Detailed Research: Economic Perspectives on MetLife, Callon Petroleum, Five9, Ballard Power, Infinity Pharmaceuticals, and Commercial Vehicle Group What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-07-18 10:50AM	Bristol-Myers, Infinity to Test Opdivo Combo for Bladder Cancer Zacks +6.41%
Nov-06-18 03:24PM	Infinity (INFI) Q3 Earnings Beat Estimates, Revenues Up Y/Y Zacks
Nov-05-18 04:55PM	Infinity: 3Q Earnings Snapshot Associated Press
04:03PM	Infinity Pharmaceuticals Provides Company Update and Third Quarter 2018 Financial Results PR Newswire
06:59AM	Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer PR Newswire
06:59AM	Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer Business Wire
Nov-01-18 02:23PM	Infinity Announces IPI-549 Late-Breaking Presentation at SITC 33rd Annual Meeting PR Newswire +17.50%
Oct-29-18 08:32AM	Infinity Announces the Date of Its Third Quarter 2018 Financial Results Conference Call and Webcast PR Newswire -5.09%
Oct-17-18 07:55AM	Report: Exploring Fundamental Drivers Behind Infinity Pharmaceuticals, AxoGen, MUELLER WATER PRODUCTS, MYR Group, RealNetworks, and Odonate Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. It offers IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that selectively inhibits the enzyme phosphoinositide-3-kinase-gamma Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma (PI3K-gamma), which is in Phase 1/1b clinical study. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib, as well as duvelisib program for patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol-Myers Squibb Company. Infinity Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience